DrugPatentWatch Database Preview

Fluocinolone acetonide - Generic Drug Details

« Back to Dashboard

What are the generic sources for fluocinolone acetonide and what is the scope of freedom to operate?

Fluocinolone acetonide is the generic ingredient in seventeen branded drugs marketed by Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Invatech, Perrigo New York, Pharmafair, Taro, Usl Pharma, Allergan Herbert, Savage Labs, Medimetriks Pharms, Alimera Sciences Inc, Bausch And Lomb, Eyepoint Pharms, Hill Dermac, Anda Repository, Akorn, Amneal, Lyne, Perrigo Israel, Glenmark Pharms Ltd, Pharmaderm, Galderma Labs Lp, Actavis Labs Ut Inc, Encube Ethicals, Glasshouse Pharms, Lupin, and Morton Grove, and is included in seventy-three NDAs. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fluocinolone acetonide has one hundred and seventy-six patent family members in twenty-seven countries.

There are twelve drug master file entries for fluocinolone acetonide. Twenty suppliers are listed for this compound.

Summary for fluocinolone acetonide

International Patents:	176
US Patents:	10
Tradenames:	17
Applicants:	28
NDAs:	73
Drug Master File Entries:	12
Suppliers / Packagers:	20
Bulk Api Vendors:	67
Clinical Trials:	29
Patent Applications:	7,041
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for fluocinolone acetonide
What excipients (inactive ingredients) are in fluocinolone acetonide?	fluocinolone acetonide excipients list
DailyMed Link:	fluocinolone acetonide at DailyMed

See drug prices for fluocinolone acetonide

Recent Clinical Trials for fluocinolone acetonide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Lee's Pharmaceutical Limited	Phase 3
St. Michael's Hospital, Toronto	Phase 2
Pradeepa Yoganathan	Phase 2

See all fluocinolone acetonide clinical trials

Pharmacology for fluocinolone acetonide

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for fluocinolone acetonide

Anti-Inflammatory Agents

Glucocorticoids

US Patents and Regulatory Information for fluocinolone acetonide

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glasshouse Pharms	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	SOLUTION;TOPICAL	209596-001	Dec 26, 2017	AT	RX	No	No
Fougera Pharms Inc	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	SOLUTION;TOPICAL	088167-001	Dec 16, 1982	AT	RX	No	No
Amneal	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	OIL;TOPICAL	201764-001	Oct 17, 2011	AT	RX	No	No
Savage Labs	FLUOTREX	fluocinolone acetonide	CREAM;TOPICAL	088173-001	Mar 9, 1983		DISCN	No	No

Expired US Patents for fluocinolone acetonide

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alimera Sciences Inc	ILUVIEN	fluocinolone acetonide	IMPLANT;INTRAVITREAL	201923-001	Sep 26, 2014
Eyepoint Pharms	YUTIQ	fluocinolone acetonide	IMPLANT;INTRAVITREAL	210331-001	Oct 12, 2018
Eyepoint Pharms	YUTIQ	fluocinolone acetonide	IMPLANT;INTRAVITREAL	210331-001	Oct 12, 2018
Alimera Sciences Inc	ILUVIEN	fluocinolone acetonide	IMPLANT;INTRAVITREAL	201923-001	Sep 26, 2014

International Patents for fluocinolone acetonide

Country	Patent Number	Estimated Expiration
Japan	5918195
Hong Kong	1053263
Cyprus	1108685
South Africa	200604777

Supplementary Protection Certificates for fluocinolone acetonide

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2233112	132014902285293	Italy		PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504
2233112	122014000063	Germany		PRODUCT NAME: FLUOCINOLONACETONID; NAT. REGISTRATION NO/DATE: 82809.00.00 20120720; FIRST REGISTRATION: GB PL 27813/0001 20120504